Search results
Quadruplet Regimens Have Become Standard for Multiple Myeloma
MedPage Today· 5 days agoWhile triplet regimens were once standard for newly diagnosed multiple myeloma, more recent studies...
Man, 91, makes history by being first in England to receive artificial cornea
Daily Express· 18 hours agoAfter an initial failed surgery with a human cornea, Farley’s surgeon offered him the chance to skip...
Greeley girl fights rare, life-threatening blood disorder with positive attitude, deep bonds with...
Greeley Tribune· 4 days agoAubrie Dawson experienced a roller coaster of health scares that put her in a lot of...
Cancer Survivors Are Sharing The Weird Symptom That Made Them Go "Hm, Something Isn't Right Here,"...
BuzzFeed via Yahoo News· 4 days ago"If they tell you it might be cancer and have you come back in a couple of weeks for a biopsy, say...
Advances in CAR T-Cell Therapy for Multiple Myeloma
MedPage Today· 5 days agoB-cell maturation antigen (BCMA)-directed CAR T-cell therapies are now established options for treating multiple myeloma after relapse, but efforts are...
TECVAYLI® (teclistamab-cqyv) shows sustained deep and durable responses in patients with relapsed or...
Forrest City Times-Herald· 2 days ago"With the longest follow-up of any bispecific antibody, teclistamab demonstrates continued deep and durable responses observed in patients with relapsed or refractory multiple myeloma who have ...
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI...
Benzinga· 6 days agoREDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting
Triplet Notches Survival Win in Heavily Pretreated DLBCL
MedPage Today· 3 days agoBenefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant
Mobile app aims to help identify graft-versus-host disease earlier
Medical Xpress· 2 days agoTreatment for cGVHD works best when the condition is caught as early as possible, but sometimes weeks or months can pass between a patient's follow-up visits and symptoms can develop in the ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoAlmost anyone with a weakened or suppressed immune system could be at a heightened risk of developing an invasive mold infection (IMI). Two of the most common IMIs include invasive aspergillosis ...